- Date2025-02-17
HIRA to Unveil Diabetic Care Status in commemoration
of World Diabetes Day
- 2023 diabetic patients of 3,828,682 people, taking up 7.4% of entire population -
|
|
<Main Content> |
|
|
|
| |
|
○ [Diabetes] 2023 diabetic patients of 3,828,682 people, per-capita medical fee of 307,289 won, and combined medical fee of 1.176.5 billion won - Patients number up by 18.6% (annual average 4.4%) (up by 19.6% for men, 17.3% for women) - Annual average 7.1% up in recent 5 year-national insurance medical fee combination; and 5.9% up in diabetes - Disorders of lipoprotein metabolism and other lipidemias accounting for 39.8% of the highest in frequent comorbidities of diabetes - Diabetic patient accompanied with hypertension constituting 48.2% | ||
□ The Health Insurance Review and Assessment Service (HIRA), led by President Kang Jung-Gu, unveiled diabetic care status in the recent 5 years (2019-2023) on November 14, 2024, in commemoration of World Diabetes World.
□ The analysis of recent 5-year diabetic care progress presented an increase (2019-2023): by 18.6% (annual average 4.4%) in patient numbers; by 25.7% (annual average 5.9%) in medical fees; and in the proportion of men in gender ratio.
○ The number of male patients rose 19.6% (annual average 4.6%) for half a decade, with a 30.1% rise of annually combined medical fees (annual average 6.8%).
- patients number: 1,794,777 people (2019) to 2,146,381 people (2023)
- combined medical fees: 505.3 billion won (2019) to 657.2 billion won (2023)
○ The proportion of female patients numbers grew by 17.3% for 5 years (annual average 4.1%), along with a 20.6% increase in the annual combination of medical fees (annual average 4.8%).
- patients number: 1,433,783 people (2019) to 1,682,301 people (2023)
- combined medical fees: 430.4 billion won (2019) to 519.3 billion won (2023)
|
[Table 1] Gender-based diabetic care status in recent 5 years (2019-2023) (Unit: people, billion won, won, %) | |||||||||
|
Classification |
2019 |
2020 |
2021 |
2022 |
2023 |
Increase & Decrease | |||
|
Annual average |
2023 over 2019 | ||||||||
|
Diabetes |
Total |
No. of Patients |
3,228,560 |
3,348,237 |
3,569,294 |
3,697,999 |
3,828,682 |
▲ 4.4 |
▲ 18.6 |
|
Combined medical fees |
9,357 |
9,719 |
10,549 |
11,038 |
11,765 |
▲ 5.9 |
▲ 25.7 | ||
|
Per-capita medical fee |
289,833 |
290,271 |
295,547 |
298,496 |
307,289 |
▲ 1.5 |
▲ 6.0 | ||
|
Male |
No. of Patients |
1,794,777 |
1,868,692 |
1,988,924 |
2,065,644 |
2,146,381 |
▲ 4.6 |
▲ 19.6 | |
|
Combined medical fees |
5,053 |
5,321 |
5,825 |
6,127 |
6,572 |
▲ 6.8 |
▲ 30.1 | ||
|
Per-capita medical fee |
281,553 |
284,747 |
292,873 |
296,623 |
306,198 |
▲ 2.1 |
▲ 8.8 | ||
|
Female |
No. of Patients |
1,433,783 |
1,479,545 |
1,580,370 |
1,632,355 |
1,682,301 |
▲ 4.1 |
▲ 17.3 | |
|
Combined medical fees |
4,304 |
4,398 |
4,724 |
4,911 |
5,193 |
▲ 4.8 |
▲ 20.6 | ||
|
Per-capita medical fee |
300,196 |
297,248 |
298,913 |
300,866 |
308,681 |
▲ 0.7 |
▲ 2.8 | ||
□ The analysis of 5-year diabetic care progress per in-patient or out-patient (2019-2023) resulted in a 12.5% decrease (annual average 3.3%) in in-patient claim cases; and a 9.6% rise of out-patient cases.
○ In-hospital patients numbers fell 6.1% (annual average 1.6%) for the last 5 years, 3.0% up from annual combined medical fees (annual average 0.7%).
- patients number: 94,248 people (2019) to 88,465 people (2023)
- combined medical fees: 283.8 billion won (2019) to 292.4 billion won (2023)
- per-case medical fee: 1,677,344 won (2019) to 1,975,510 won (2023)
○ Out-hospital patients numbers climbed 18.7% (annual average 4.4%) for half a decade, 35.6% up from annual combined medical fees (annual average 7.9%).
- patients number: 3,210,072 people (2019) to 3,810,377 people (2023)
- combined medical fees: 651.9 billion won (2019) to 884.1 billion won (2023)
- per-case medical fee: 28,658 won (2019) to 35,451 won (2023)
|
[Table 2] Diabetic care status by in-patient or out-patient in recent 5 years (2019-2023) (Unit: people, case, billion won, won, %) | |||||||||
|
Classification |
2019 |
2020 |
2021 |
2022 |
2023 |
Increase & Decrease | |||
|
Annual average |
2023 over 2019 | ||||||||
|
Diabetes |
In-patient |
No. of Patients |
94,248 |
86,322 |
89,380 |
95,789 |
88,465 |
▼ 1.6 |
▼ 6.1 |
|
No. of claims |
169,224 |
155,367 |
154,635 |
162,080 |
148,036 |
▼ 3.3 |
▼ 12.5 | ||
|
Total claims |
2,838 |
2,772 |
2,785 |
2,771 |
2,924 |
▲ 0.7 |
▲ 3.0 | ||
|
Per-capita medical fee |
3,011,701 |
3,210,688 |
3,115,837 |
2,892,984 |
3,305,789 |
▲ 2.4 |
▲ 9.8 | ||
|
Per-case medical fee |
1,677,344 |
1,783,860 |
1,800,973 |
1,709,748 |
1,975,510 |
▲ 4.2 |
▲ 17.8 | ||
|
Out-patient |
No. of Patients |
3,210,072 |
3,330,501 |
3,550,138 |
3,674,638 |
3,810,377 |
▲ 4.4 |
▲ 18.7 | |
|
No. of claims |
22,747,017 |
23,109,956 |
24,275,470 |
24,531,986 |
24,937,675 |
▲ 2.3 |
▲ 9.6 | ||
|
Total claims |
6,519 |
6,947 |
7,764 |
8,267 |
8,841 |
▲ 7.9 |
▲ 35.6 | ||
|
Per-capita medical fee |
203,078 |
208,600 |
218,696 |
224,980 |
232,015 |
▲ 3.4 |
▲ 14.2 | ||
|
Per-case medical fee |
28,658 |
30,063 |
31,983 |
33,700 |
35,451 |
▲ 5.5 |
▲ 23.7 | ||
□ Taking the status of patients number against the population by age for 5 years (2019-2023) into consideration, it displayed that more than 15 people among 100 in their 60s or older were diagnosed with diabetes, with age groups in their 20s or younger showing a considerable increase in the patient rate.
○ The age groups who were frequented by the diagnosis of diabetics in 2023 are the following: 21.79% in their 70s (864,383 people); 18.46% in their 80s or older (434,449 people); and 16.4% in their 60s(1,251,421 people) in order.
|
[Table 3] Diabetic care status by age in recent 5 years (20192023) (Unit: people, %)
| |||||||
|
Classification |
2019 |
2020 |
2021 |
2022 |
2023 |
Increase & decrease in patient ratio | |
|
No. of Patients (Patients ratio) |
No. of Patients (Patients ratio) |
No. of Patients (Patients ratio) |
No. of Patients (Patients ratio) |
No. of Patients (Patients ratio) |
Annual average |
2023 aginst 2019 | |
|
Subtotal |
3,228,560 |
3,348,237 |
3,569,294 |
3,697,999 |
3,828,682 |
▲ 4.4 |
▲ 18.6 |
|
(6.23) |
(6.46) |
(6.91) |
(7.19) |
(7.46) | |||
|
Under in their 10s |
978 |
907 |
1,146 |
1,153 |
1,231 |
▲ 5.9 |
▲ 25.9 |
|
(0.02) |
(0.02) |
(0.03) |
(0.03) |
(0.04) | |||
|
In their 10s |
10,395 |
10,037 |
12,697 |
12,612 |
12,863 |
▲ 5.5 |
▲ 23.7 |
|
(0.21) |
(0.21) |
(0.27) |
(0.27) |
(0.28) | |||
|
In their 20s |
32,735 |
35,327 |
41,545 |
42,772 |
43,568 |
▲ 7.4 |
▲ 33.1 |
|
(0.48) |
(0.52) |
(0.62) |
(0.67) |
(0.70) | |||
|
In their 30s |
119,580 |
121,668 |
131,463 |
131,823 |
133,069 |
▲ 2.7 |
▲ 11.3 |
|
(1.69) |
(1.77) |
(1.96) |
(1.99) |
(2.02) | |||
|
In their 40s |
378,482 |
381,586 |
401,452 |
406,713 |
409,512 |
▲ 2.0 |
▲ 8.2 |
|
(4.51) |
(4.60) |
(4.92) |
(5.04) |
(5.17) | |||
|
In their 50s |
846,206 |
852,789 |
876,797 |
880,337 |
887,344 |
▲ 1.2 |
▲ 4.9 |
|
(9.76) |
(9.86) |
(10.15) |
(10.22) |
(10.20) | |||
|
In their 60s |
993,584 |
1,058,852 |
1,153,081 |
1,209,388 |
1,251,421 |
▲ 5.9 |
▲ 26.0 |
|
(15.74) |
(15.70) |
(16.09) |
(16.34) |
(16.40) | |||
|
In their 70s |
740,981 |
764,773 |
799,248 |
838,291 |
864,383 |
▲ 3.9 |
▲ 16.7 |
|
(20.61) |
(20.68) |
(21.51) |
(21.91) |
(21.79) | |||
|
In their 80s or older |
299,964 |
323,781 |
359,354 |
407,765 |
434,449 |
▲ 9.7 |
▲ 44.8 |
|
(15.91) |
(16.16) |
(17.05) |
(18.07) |
(18.46) | |||
|
* No. of patients is the value without the same person duplication. Without consideration of it, duplication can transpire. * Rate of patients is the ratio of patients against age-specific population. | |||||||
□ In light of frequent comorbidities of diabetes in 2023, such order of frequency came as: 39.8% (1,524,737 people) of disorders of lipoprotein metabolism and other lipidemias, 33.7% (1,290,924 people) of essential(primary) hypertension, and 3.0% (113,707 people) of other diseases of liver.
|
[Table 4] The care status of frequent comorbidities of diabetes(top 5) (Unit: people, %) | |||||||
|
Disease |
Name of Disease |
2019 |
2020 |
2021 |
2022 |
2023 | |
|
No. of patients |
Ratio | ||||||
|
E78 |
Disorders of lipoprotein metabolism and other lipidemias |
1,179,430 |
1,254,736 |
1,358,283 |
1,439,130 |
1,524,737 |
39.8 |
|
I10 |
Essential(primary) hypertension |
1,064,640 |
1,120,579 |
1,193,845 |
1,240,941 |
1,290,924 |
33.7 |
|
K76 |
Other diseases of liver |
117,045 |
118,352 |
121,890 |
116,657 |
113,707 |
3.0 |
|
K21 |
Gastro-oesophageal reflux |
97,758 |
104,256 |
109,207 |
106,091 |
105,179 |
2.7 |
|
G63 |
Polyneuropathy in diseases classified elsewhere |
95,447 |
93,370 |
94,718 |
91,465 |
91,708 |
2.4 |
|
* Comorbidity is based upon secondary diagnosis. ** Frequent comorbidity order makes use of 2023 patients number. *** The proportion is the ratio of diabetic patients number against patients number with comorbidity of such disease. | |||||||
○ Recent 5 years (2019-2023) record showed that the number of patients with hypertension diseases in diabetes rose 23.1% (annual average 5.3%), and annual combined medical fees 24.5% (annual average 5.6%).
- patients number: 1,499,308 people (2019) to 1,845,265 people (2023)
- combined medical fees: 440.7 billion won (2019) to 548.7 billion won (2023)
- per-capita medical fee: 293,938 won (2019) to 297,355 won (2023)
○ Recent 5 years (2019-2023) record indicated that the number of patients with cardiovascular diseases in diabetes rose 14.8% (annual average 3.5%), and annual combined medical fees 24.1% (annual average 5.5%).
- patients number: 223,647 people (2019) to 256,801 people (2023)
- combined medical fees: 88 billion won (2019) to 109.1 billion won (2023)
- per-capita medical fee: 393,279 won (2019) to 424,935 won (2023)
|
[Table 5] Diabetic care status concurrently claimed for hypertension and cardiovascular diseases in recent 5 years (2019-2023) (Unit: people, billion won, won, %) | ||||||||
|
Classification |
2019 |
2020 |
2021 |
2022 |
2023 |
Increase & decrease | ||
|
Annual average |
2023 against 2019 | |||||||
|
Diabetes & Hypertension |
No. of Patients |
1,499,308 |
1,588,193 |
1,685,847 |
1,763,369 |
1,845,265 |
▲ 5.3 |
▲ 23.1 |
|
Combined medical fees |
4,407 |
4,571 |
4,932 |
5,136 |
5,487 |
▲ 5.6 |
▲ 24.5 | |
|
Per-capita medical fees |
293,938 |
287,828 |
292,567 |
291,273 |
297,355 |
▲ 0.3 |
▲ 1.2 | |
|
Diabetes & Cardiovascular diseases |
No. of Patients |
223,647 |
231,153 |
244,332 |
248,326 |
256,801 |
▲ 3.5 |
▲ 14.8 |
|
Combined medical fees |
880 |
922 |
982 |
999 |
1,091 |
▲ 5.5 |
▲ 24.1 | |
|
Per-capita medical fees |
393,279 |
399,055 |
401,885 |
402,228 |
424,935 |
▲ 2.0 |
▲ 8.0 | |
|
* Hypertension (secondary diagnosis):I10-I15 (Korean Standard Classification of Diseases (2020) by the National Statistical Office) * Cardiovascular disease (secondary diagnosis): I20~I25, I42~I43, and I50~I52 (Korean Standard Classification of Diseases (2020) by the National Statistical Office) | ||||||||
□ Director General of the Big Data Department said “Diabetic care status of recent 5 years explained that most of the patients are in their 40s or older, and yet there is a rising rate of patients in their 20s or younger, thereby calling for entire age groups to do a regular checkup to identify diabetes early and control it.”
○ The HIRA portal provides the review result of medical institutions for diabetes, furnishing information of regional diabetic care status via the healthcare open system.
|
※ Data Analysis Criteria ○ Jan 2019-Dec 2023 based upon care-given day of national insurance (reflecting Jan 2019-Apr 2024 review result) ○ Primary diagnosis of Diabetes ((E10~E14), secondary diagnosis of hypertension (I10~I15), secondary diagnosis of cardiovascular diseases (I20~I25, I42~I43, I50~I52) ※ Korean Standard Classification of Diseases (2020) of National Statistical Office, save pharmacies and oriental clinics ○ Disease-specific status came on the back of claim data in which a patient was granted a primary diagnosis, just with his or her complaining and symptoms, by a medical institution, while the diagnosis was uncertain along the way, likely differing from final definite diagnosis. ○ Age is measured on a basis of international age at the medically serviced time. ○ Patients number is the value without duplication of the same patient in a category, and yet duplication can occur when it just adds up the value of other category: for instance, a patient’s age was changed in the course of medical procedures and then each different age is used for the calculation of patients number. |
- Prev
- [News] HIRA to Hold Discussion on Antimicrobial Resistance and Use Control in company with WHO
- Next
- No Next Article
